Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,552
datasets available to search
ShareScore release 0.8.0
Dataset results
2,552 results for “Glioblastoma”
Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov study NCT00274833. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help
ClinicalTrials.gov study NCT05063682. IPD Sharing: NO. Countries: 2. Publications: 0.
Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma
ClinicalTrials.gov study NCT03383978. IPD Sharing: NO. Countries: 1. Publications: 0.
Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency
ClinicalTrials.gov study NCT07385846. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
ClinicalTrials.gov study NCT04822688. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
ClinicalTrials.gov study NCT01632228. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
ClinicalTrials.gov study NCT06059690. IPD Sharing: NO. Countries: 1. Publications: 0.
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
ClinicalTrials.gov study NCT06061809. IPD Sharing: NO. Countries: 1. Publications: 0.
Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma
ClinicalTrials.gov study NCT05341947. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab
ClinicalTrials.gov study NCT01788280. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting
ClinicalTrials.gov study NCT02717962. IPD Sharing: NO. Countries: 1. Publications: 0.
OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
ClinicalTrials.gov study NCT06558214. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
ClinicalTrials.gov study NCT02348255. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)
ClinicalTrials.gov study NCT07375992. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment Intensification With Temozolomide in Adults With a Glioblastoma
ClinicalTrials.gov study NCT03663725. IPD Sharing: NO. Countries: 1. Publications: 0.
Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
ClinicalTrials.gov study NCT04214392. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov study NCT00316849. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma
ClinicalTrials.gov study NCT02902757. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov study NCT02331498. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
ClinicalTrials.gov study NCT01205334. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.